Correlation Between Purple Biotech and Endonovo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and Endonovo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and Endonovo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and Endonovo Therapeutics, you can compare the effects of market volatilities on Purple Biotech and Endonovo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of Endonovo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and Endonovo Therapeutics.
Diversification Opportunities for Purple Biotech and Endonovo Therapeutics
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Purple and Endonovo is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and Endonovo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Endonovo Therapeutics and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with Endonovo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Endonovo Therapeutics has no effect on the direction of Purple Biotech i.e., Purple Biotech and Endonovo Therapeutics go up and down completely randomly.
Pair Corralation between Purple Biotech and Endonovo Therapeutics
Given the investment horizon of 90 days Purple Biotech is expected to generate 0.79 times more return on investment than Endonovo Therapeutics. However, Purple Biotech is 1.27 times less risky than Endonovo Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Endonovo Therapeutics is currently generating about 0.0 per unit of risk. If you would invest 1,876 in Purple Biotech on September 4, 2024 and sell it today you would lose (1,219) from holding Purple Biotech or give up 64.98% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Purple Biotech vs. Endonovo Therapeutics
Performance |
| Timeline |
| Purple Biotech |
| Endonovo Therapeutics |
Purple Biotech and Endonovo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Purple Biotech and Endonovo Therapeutics
The main advantage of trading using opposite Purple Biotech and Endonovo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, Endonovo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endonovo Therapeutics will offset losses from the drop in Endonovo Therapeutics' long position.| Purple Biotech vs. Pluri Inc | Purple Biotech vs. BioLineRx | Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Anebulo Pharmaceuticals |
| Endonovo Therapeutics vs. Bio Path Holdings | Endonovo Therapeutics vs. Cingulate | Endonovo Therapeutics vs. Purple Biotech | Endonovo Therapeutics vs. Soleno Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |